Litcius/Paper detail

Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial

Chi‐Leung Chiang, K.W. Chiu, Kenneth Sik Kwan Chan, Francis Ann Shing Lee, James Chun Bong Li, Catherine Wing Suet Wan, Wing Chiu Dai, Tai‐Chung Lam, Wenqi Chen, Natalie Wong, Andy Lai Yin Cheung, Venus Wan Yan Lee, Vince Wing Hang Lau, Aya El Helali, Kwan Man, Feng Kong, Chung Mau Lo, Albert Chan

2022˜The œLancet. Gastroenterology & hepatology137 citationsDOI

Topics & Concepts

MedicineHepatocellular carcinomaClinical endpointRadiation therapyLiver functionPopulationInternal medicineOncologySurgeryUrologyClinical trialEnvironmental healthHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesCancer Immunotherapy and Biomarkers
Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial | Litcius